Notably, recent studies have found that HDAC6 inhibition resulted in brain protection in several types of central nervous system disorders including Alzheimer’s disease, Huntington’s disease, and ischemia stroke (Wang et al., 2016; Zhang et al., 2019, 2014). The gene discussed is HDAC6; the disease is early-onset autosomal dominant Alzheimer disease.